CD8A and non-small cell lung carcinoma: A meta-analysis encompassing 14,395 NSCLC patients revealed that high CD8+ TILs were associated with improved prognosis predictions for OS (3-year OS AUC: 0.659; 5-year OS AUC: 0.665) [21].